Regulatory Framework: Key FDA Guidance Documents for Nasal Sprays The foundation of nasal spray testing requirements in the United States is established by two primary FDA guidance documents, both from the Center for Drug Evaluation and Research (CDER): FDA CDER 2002 Nasal Spray and Inhalation Solution, Suspension and Spray Drug Products Chemistry, Manufacturing and Controls Documentation (CMC Guidance): Defines the CMC documentation requirements for new drug applications (NDAs) and abbreviated new drug applications (ANDAs) involving nasal spray and inhalation drug products
People with digestive issues, from leaky gut to ulcers, have reported significant improvements
For patients with impaired liver function or genetic variants affecting B12 metabolism, methylcobalamin may be preferable
For best results, use daily or between users
Unlike virtually every other peptide, BPC-157 remains stable in human gastric juice for over 24 hours
Magnesium Chloride (1-2g) Magnesium plays a role in over 300 enzymatic reactions in the body
